Cargando…
5’-adenosine monophosphate mediated cooling treatment enhances ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) stability in vivo
BACKGROUND: Gene mutations that produce misprocessed proteins are linked to many human disorders. Interestingly, some misprocessed proteins retained their biological function when stabilized by low temperature treatment of cultured cells in vitro. Here we investigate whether low temperature treatmen...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559075/ https://www.ncbi.nlm.nih.gov/pubmed/26335336 http://dx.doi.org/10.1186/s12929-015-0178-3 |
_version_ | 1782388718331494400 |
---|---|
author | Zhang, Yueqiang O’Brien, William G. Zhao, Zhaoyang Lee, Cheng Chi |
author_facet | Zhang, Yueqiang O’Brien, William G. Zhao, Zhaoyang Lee, Cheng Chi |
author_sort | Zhang, Yueqiang |
collection | PubMed |
description | BACKGROUND: Gene mutations that produce misprocessed proteins are linked to many human disorders. Interestingly, some misprocessed proteins retained their biological function when stabilized by low temperature treatment of cultured cells in vitro. Here we investigate whether low temperature treatment in vivo can rescue misfolded proteins by applying 5’-AMP mediated whole body cooling to a Cystic Fibrosis (CF) mouse model carrying a mutant cystic fibrosis transmembrane conductance regulator (CFTR) with a deletion of the phenylalanine residue in position 508 (ΔF508-CFTR). Low temperature treatment of cultured cells was previously shown to be able to alleviate the processing defect of ΔF508-CFTR, enhancing its plasma membrane localization and its function in mediating chloride ion transport. RESULTS: Here, we report that whole body cooling enhanced the retention of ΔF508-CFTR in intestinal epithelial cells. Functional analysis based on β-adrenergic dependent salivary secretion and post-natal mortality rate revealed a moderate but significant improvement in treated compared with untreated CF mice. CONCLUSIONS: Our findings demonstrate that temperature sensitive processing of mutant proteins can be responsive to low temperature treatment in vivo. |
format | Online Article Text |
id | pubmed-4559075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45590752015-09-04 5’-adenosine monophosphate mediated cooling treatment enhances ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) stability in vivo Zhang, Yueqiang O’Brien, William G. Zhao, Zhaoyang Lee, Cheng Chi J Biomed Sci Research BACKGROUND: Gene mutations that produce misprocessed proteins are linked to many human disorders. Interestingly, some misprocessed proteins retained their biological function when stabilized by low temperature treatment of cultured cells in vitro. Here we investigate whether low temperature treatment in vivo can rescue misfolded proteins by applying 5’-AMP mediated whole body cooling to a Cystic Fibrosis (CF) mouse model carrying a mutant cystic fibrosis transmembrane conductance regulator (CFTR) with a deletion of the phenylalanine residue in position 508 (ΔF508-CFTR). Low temperature treatment of cultured cells was previously shown to be able to alleviate the processing defect of ΔF508-CFTR, enhancing its plasma membrane localization and its function in mediating chloride ion transport. RESULTS: Here, we report that whole body cooling enhanced the retention of ΔF508-CFTR in intestinal epithelial cells. Functional analysis based on β-adrenergic dependent salivary secretion and post-natal mortality rate revealed a moderate but significant improvement in treated compared with untreated CF mice. CONCLUSIONS: Our findings demonstrate that temperature sensitive processing of mutant proteins can be responsive to low temperature treatment in vivo. BioMed Central 2015-09-04 /pmc/articles/PMC4559075/ /pubmed/26335336 http://dx.doi.org/10.1186/s12929-015-0178-3 Text en © Zhang et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhang, Yueqiang O’Brien, William G. Zhao, Zhaoyang Lee, Cheng Chi 5’-adenosine monophosphate mediated cooling treatment enhances ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) stability in vivo |
title | 5’-adenosine monophosphate mediated cooling treatment enhances ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) stability in vivo |
title_full | 5’-adenosine monophosphate mediated cooling treatment enhances ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) stability in vivo |
title_fullStr | 5’-adenosine monophosphate mediated cooling treatment enhances ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) stability in vivo |
title_full_unstemmed | 5’-adenosine monophosphate mediated cooling treatment enhances ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) stability in vivo |
title_short | 5’-adenosine monophosphate mediated cooling treatment enhances ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) stability in vivo |
title_sort | 5’-adenosine monophosphate mediated cooling treatment enhances δf508-cystic fibrosis transmembrane conductance regulator (cftr) stability in vivo |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559075/ https://www.ncbi.nlm.nih.gov/pubmed/26335336 http://dx.doi.org/10.1186/s12929-015-0178-3 |
work_keys_str_mv | AT zhangyueqiang 5adenosinemonophosphatemediatedcoolingtreatmentenhancesdf508cysticfibrosistransmembraneconductanceregulatorcftrstabilityinvivo AT obrienwilliamg 5adenosinemonophosphatemediatedcoolingtreatmentenhancesdf508cysticfibrosistransmembraneconductanceregulatorcftrstabilityinvivo AT zhaozhaoyang 5adenosinemonophosphatemediatedcoolingtreatmentenhancesdf508cysticfibrosistransmembraneconductanceregulatorcftrstabilityinvivo AT leechengchi 5adenosinemonophosphatemediatedcoolingtreatmentenhancesdf508cysticfibrosistransmembraneconductanceregulatorcftrstabilityinvivo |